Immunologic Tests
5
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
75%
3 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays
A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines
A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological Assays
Study in Allergic Adults to Support the Development of Immunological Assays
A Prospective Study of a New Immunological Fecal Occult Blood Test